fda warning letters glp-1 compounding september 2025 CDER Jump 50% in FY — What That Means for Industry FDA telehealth crackdown highlights role

In this phase II of the test, the home arm, the arm explored in phase I, designated the familiar arm, and the third arm previously closed arm, designated the novel arm, were open for exploration

To further reduce contamination risks, aliquot the reconstituted solution into sterile microtubes and label each one with the contents, concentration, and reconstitution date

Most GLP-1 side effects start a few days after you receive a dose of the medication

The companies argued compounding hurt their sales and theyve raised safety and quality doubts over compounded version

Its making for healthier people and healthier budgets, said Jay Ludlam, deputy secretary for North Carolinas Medicaid program